TABLE 3.

PROMIS F-SF Items: Correlations, Means, and Standard Deviations in Five Samples

Fibromyalgia syndrome (FMS) (N = 72 )^a								Sickle cell disease (N = 60)

Item	1.	2.	3.	4.	5.	6.	7.	Item	1.	2.	3.	4.	5.	6.	7.
1	1.00	.52	.46	.28	.21	.14	.01	1	1.00	.56	.59	.57	.58	.53	.19
2	.52	1.00	.68	.58	.50	.35	.07	2	.56	1.00	.65	.54	.56	.59	.05
3	.46	.68	1.00	.59	.54	.32	.31	3	.59	.65	1.00	.72	.60	.52	.06
4	.28	.58	.59	1.00	.50	.35	.15	4	.57	.54	.72	1.00	.60	.39	.16
5	.21	.50	.54	.50	1.00	.45	−.06	5	.58	.56	.60	.60	1.00	.44	.07
6	.14	.35	.32	.35	.45	1.00	.02	6	.53	.59	.52	.39	.44	1.00	−.03
7	.01	.07	.31	.15	−.06	.02	1.00	7	.19	.05	.06	.16	.07	−.03	1.00
M	4.31	3.47	3.72	3.68	3.04	2.53	3.99	M	3.55	2.50	2.97	2.78	2.50	2.00	3.52
SD	0.66	0.84	0.97	0.90	1.03	1.11	1.12	SD	0.85	1.08	1.06	1.12	1.14	1.04	1.14

Cardio-metabolic risk (N = 63)^a								Pregnancy (N = 72)^a

Item	1.	2.	3.	4.	5.	6.	7.	Item	1.	2.	3.	4.	5.	6.	7.
1	1.00	.54	.54	.52	.52	.30	.44	1	1.00	.36	.50	.25	.07	.21	.11
2	.54	1.00	.57	.42	.52	.37	.22	2	.36	1.00	.62	.44	.43	.31	−.12
3	.54	.57	1.00	.62	.74	.52	.42	3	.50	.62	1.00	.45	.51	.33	.10
4	.52	.42	.62	1.00	.69	.33	.33	4	.25	.44	.45	1.00	.49	.35	−.05
5	.52	0.52	.74	.69	1.00	.42	.39	5	.07	.43	.51	.49	1.00	.47	.04
6	.30	.37	.52	.33	.42	1.00	.23	6	.21	.31	.33	.35	.47	1.00	−.05
7	.44	.22	.42	.33	.39	.23	1.00	7	.11	−.12	.10	−.05	.04	−.05	1.00
M	3.67	2.16	2.78	2.43	2.32	1.63	3.46	M	3.93	2.97	3.13	2.89	2.49	2.07	3.88
SD	0.86	1.03	0.97	1.15	0.93	0.89	1.09	SD	0.91	1.06	1.13	1.19	1.05	1.04	1.17

Healthy controls (N = 40)^a

Item	1.	2.	3.	4.	5.	6.	7.
1	1.00	.68	.70	.63	.64	.47	.34
2	.68	1.00	.76	.65	.65	.46	.32
3	.70	.76	1.00	.72	.72	.51	.36
4	.63	.65	.72	1.00	.86	.59	.38
5	.64	.65	.72	.86	1.00	.72	.30
6	.47	.46	.51	.59	.72	1.00	.13
7	.34	.32	.36	.38	.30	.13	1.00
M	2.75	1.65	2.13	1.55	1.65	1.33	2.88
SD	1.03	1.00	0.97	0.93	0.95	0.69	1.28

Note. SD = standard deviation.